Genus Capital Management Inc. Eli Lilly & CO Put Options Transaction History

Genus Capital Management Inc.

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Oct 29, 2024	SELL	$772.14 - $960.02 $7.3 Million - $9.08 Million	-9,454 Reduced 77.68%	2,716 $2.41 Billion
Q2 2024 Aug 09, 2024	BUY	$724.87 - $909.04 $8.82 Million - $11.1 Million	12,170 New	12,170 $11 Billion
Q4 2023 Feb 06, 2024	BUY	$525.19 - $619.13 $1.8 Million - $2.12 Million	3,432 New	3,432 $2 Billion

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $744B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Genus Capital Management Inc., based on Form 13F filings with the SEC.

Stay updated on Genus Capital Management Inc. with notifications on news.